Health Gilead To Acquire All Remaining Rights To Potential First-In-Class Immunotherapy GS-1811 From Jounce Therapeutics December 27, 2022
Biotechnology Adaptive Biotechnologies to Present at the 41st Annual J.P. Morgan Healthcare Conference December 27, 2022
Health Bristol Myers Squibb Company (BMY) is Attracting Investor Attention: Here is What You Should Know December 26, 2022
Search
Health
